Expense Ratio Rating
4 /10
Expense Rating
0 /10
Market Score
2 /10
Category Score
5 /10
Market Size
2 /10
$NQVAX Alternatives
Similar Funds
We found 178 US Stocks Mid-Cap Value funds. Here they are ordered by FI Score.
- cmuax
- Mutual Fund
- US Stocks
- Mid-Cap Value
Columbia Select Mid Cap Value Fund Class A
Expenses: 1.16% (Better than 0% of similar funds)
This is a bad choice for a Mid-Cap Value US Stocks fund. See why »
- samvx
- Mutual Fund
- US Stocks
- Mid-Cap Value
Virtus Ceredex Mid-Cap Value Equity Fund Class A
Expenses: 1.34% (Better than 0% of similar funds)
This is a bad choice for a Mid-Cap Value US Stocks fund. See why »
- wfpcx
- Mutual Fund
- US Stocks
- Mid-Cap Value
Wells Fargo Special Mid Cap Value Fund - Class C
Expenses: 1.90% (Better than 0% of similar funds)
This is a bad choice for a Mid-Cap Value US Stocks fund. See why »
- pcmvx
- Mutual Fund
- US Stocks
- Mid-Cap Value
Principal MidCap Value Fund I Class A
Expenses: 1.38% (Better than 0% of similar funds)
This is a bad choice for a Mid-Cap Value US Stocks fund. See why »
- spvzx
- Mutual Fund
- US Stocks
- Mid-Cap Value
PGIM QMA Mid-Cap Value Fund- Class Z
Expenses: 0.84% (Better than 1% of similar funds)
This is a bad choice for a Mid-Cap Value US Stocks fund. See why »
- caapx
- Mutual Fund
- US Stocks
- Mid-Cap Value
Ariel Appreciation Fund Investor Class
Expenses: 1.14% (Better than 0% of similar funds)
This is a bad choice for a Mid-Cap Value US Stocks fund. See why »
- ddiv
- ETF
- US Stocks
- Mid-Cap Value
First Trust Dorsey Wright Momentum & Dividend ETF
Expenses: 0.60% (Better than 1% of similar funds)
This is a bad choice for a Mid-Cap Value US Stocks fund. See why »
- smvfx
- Mutual Fund
- US Stocks
- Mid-Cap Value
Virtus Ceredex Mid-Cap Value Equity Fund Class C
Expenses: 1.79% (Better than 0% of similar funds)
This is a bad choice for a Mid-Cap Value US Stocks fund. See why »
- acclx
- Mutual Fund
- US Stocks
- Mid-Cap Value
American Century Mid Cap Value Fund C Class
Expenses: 1.98% (Better than 0% of similar funds)
This is a bad choice for a Mid-Cap Value US Stocks fund. See why »